Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Here is the SEC link:

http://www.nasdaq.com/symbol/bpth/sec-filings

Personally I do not believe the BOD or management should receive ANY options based on the company's lack of performance. The COO receiving 200,000 share is excessive based on the stock price and the failure to move the company forward.

The only positive is no option grants for PN were reported.

Rather than "free" options the Board should be buying stock in the open market to show they believe in the company. Instead they dilute the shareholders interest.

In a time of limited resources the BOD should be focusing on moving our trial forward instead of spending time and shareholders money lining their pockets. There is simply no excuse for this type of stockholder abuse when the company may be delisted from Nasdaq and removed from the Russell indexes due to management's failures.